European Journal of Surgical Oncology
Volume 34, Issue 2 , Pages 185-190, February 2008

Comparison of hepatic recurrences after resection or intraoperative radiofrequency ablation indicated by size and topographical characteristics of the metastases

  • F. Leblanc

      Affiliations

    • Digestive Tumours Unit, Institut Bergonie, Comprehensive Cancer Centre, 229 cours de l'Argonne, 33076 Bordeaux, France
    • Victor-Segalen Bordeaux 2 University, 146 rue Léo-Saignat, 33076 Bordeaux, France
  • ,
  • M. Fonck

      Affiliations

    • Digestive Tumours Unit, Institut Bergonie, Comprehensive Cancer Centre, 229 cours de l'Argonne, 33076 Bordeaux, France
    • Victor-Segalen Bordeaux 2 University, 146 rue Léo-Saignat, 33076 Bordeaux, France
  • ,
  • R. Brunet

      Affiliations

    • Digestive Tumours Unit, Institut Bergonie, Comprehensive Cancer Centre, 229 cours de l'Argonne, 33076 Bordeaux, France
    • Victor-Segalen Bordeaux 2 University, 146 rue Léo-Saignat, 33076 Bordeaux, France
  • ,
  • Y. Becouarn

      Affiliations

    • Digestive Tumours Unit, Institut Bergonie, Comprehensive Cancer Centre, 229 cours de l'Argonne, 33076 Bordeaux, France
    • Victor-Segalen Bordeaux 2 University, 146 rue Léo-Saignat, 33076 Bordeaux, France
  • ,
  • S. Mathoulin-Pélissier

      Affiliations

    • Clinical Research Department, Institut Bergonie, Comprehensive Cancer Centre, 229 cours de l'Argonne, 33076 Bordeaux, France
    • Victor-Segalen Bordeaux 2 University, 146 rue Léo-Saignat, 33076 Bordeaux, France
  • ,
  • S. Evrard

      Affiliations

    • Digestive Tumours Unit, Institut Bergonie, Comprehensive Cancer Centre, 229 cours de l'Argonne, 33076 Bordeaux, France
    • Victor-Segalen Bordeaux 2 University, 146 rue Léo-Saignat, 33076 Bordeaux, France
    • Corresponding Author InformationCorresponding author. Tel.: +33 5 56 33 32 61; fax: +33 5 56 33 33 87.

Accepted 30 September 2007.

Abstract 

Aims

Intraoperative use of radiofrequency ablation (IRFA) to treat liver metastases is controversial. The aim of this study was to compare local recurrence rate and survival after IRFA versus resection.

Methods

Three groups from 99 patients were consecutively operated on for 307 liver metastases with 2years of follow up: group 1, IRFA alone (n=34); group 2, IRFA plus resection (n=28); group 3, resection alone (n=37). The choice of IRFA or resection was made on the basis of the sizes and topographies of the metastases with the goal of achieving R0 treatment.

Results

Mortality was zero; morbidity was 9%, 11% and 11% in the three groups respectively. Median follow-up after surgery was 30months. Total hepatic recurrences occurred in 59 (60%) patients. Median survival without hepatic recurrence was 17months with no difference between the three groups (P=0.474). Total local recurrence occurred in 4 (12%) patients in group 1, in 2 (8%) patients in group 2, and in 2 (6%) patients in group 3. Survival at 2years was no different in the three groups.

Conclusion

Assessing IRFA indications by size and the topographical characteristics of the liver metastases yields identical local recurrence rates to resection after 2years of follow up.

Keywords: Liver metastases, Intraoperative radiofrequency, Hepatectomy, Recurrence, Survival

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Presented as a short oral communication at the 13th Congress of the European Society of Surgical Oncology, Venice, 1 December 2006.

PII: S0748-7983(07)00557-4

doi:10.1016/j.ejso.2007.09.028

European Journal of Surgical Oncology
Volume 34, Issue 2 , Pages 185-190, February 2008